CASI Pharma to Build Manufacturing Plant in Wuxi, China

Life Science

Green Thumb Acquires Nevada’s Top Cannabis Operator

Cannabis, Life Science

Immunocore and Genentech Dig into Immuno-Oncology in Solid Tumors With Expanded Research Deal

Life Science

China National Medical Products Administration (NMPA) Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for Chronic Hepatitis B Virus (HBV) Infection

Life Science

Alphamab Oncology of Suzhou Closes $100 Million A Round for Cancer Drugs

Life Science

Eli Lilly Could Sell Some Older China Assets for up to $300 Million

Life Science

Novartis’ blood disorder drug gets FDA approval for expanded use

Life Science

WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou

Life Science

NextCure Raises $93 Million in Series B Financing

Life Science

Merck to Add Life Sciences Unit at China R&D Center

Life Science

Agilent Completes Acquisition of ACEA Biosciences

Life Science

Priority Review Granted to BeiGene’s New Drug Applications for Zanubrutinib and Tislelizumab in China

Life Science

MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys’s Novel Immuno-Oncology Agent MOR210

Life Science

Pot Delivery Startup Eaze Launches CBD Platform in First Expansion Outside California

Cannabis, Life Science

Merck drug Keytruda succeeds in late-stage esophageal cancer trial

Life Science